Global Sickle Cell Anemia Testing & Screening Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2029

“Global Sickle Cell Anemia Testing & Screening Market” is the title of an upcoming report offered by MarketResearch.Biz. The report contains information and data, and inputs from both primary and secondary data sources, that have been verified and validated by experts in the target market. The report presents a thorough study of revenues, historical data, and information, key developments, and strategies by major players that offer vital insights and perspectives in various scenarios market. Besides critical data and related information, the report includes key trends (both present and future), factors that are driving market growth, factors that are or could be potential restraints to market growth, as well as opportunities that can be leveraged for potential revenue generation in untapped regions and countries. It also covers threats or challenges for existing as well as new entrants in the market. The global sickle cell anemia testing & screening market has been segmented on the basis of technology, age group, sector type, as well as regions and countries.

Overview:

Sickle cell anemia is an inherited red blood cell disorder in which there aren’t enough healthy red blood cells to carry oxygen throughout your body. Normally, the flexible, round red cells move easily through blood vessels. The only to determine if a person has sickle cell disease, sickle cell trait, and other abnormal hemoglobinopathies is through a special type of blood test.

Dynamics:

Numerous initiatives undertaken by government bodies towards supporting the diagnosis of sickle cell anemia is a factor that is expected to boost revenue growth of the global sickle cell anemia testing & screening market.

The success of newborn screening programs being undertaken on a pilot-scale, across countries that are rife with sickle cell anemia cases (Kenya, Congo, Ghana, etc.), are leading respective governments to mandate further initiatives that are anticipated to fuel the revenue growth of this global market in the years to come.

The development of hand-held, non-invasive digital technologies that allow for the detection of sickle cell disease, are aimed at overcoming hindrances concerning sickle cell anemia diagnosis and treatment. Market players are focusing on the development of point-of-care tests through methods such as densitometry, microfluidic electrophoresis, lateral flow immunoassay, etc. that are affordable, portable, specific and highly sensitive.

Segmentation of the global sickle cell anemia testing & screening market is as follows:

In terms of technology, the hemoglobin electrophoresis segment accounted for the majority revenue share of the global sickle cell anemia testing & screening market in 2019. The point-of-care segment is slated to register considerable revenue growth in the coming years.

On the basis of age group, the newborn screening segment accounted for the highest number of revenue shares of the global sickle cell anemia testing & screening market, however, the adult screening segment is expected to index the fastest rate of revenue growth over the next 10 years.

With respect to sector type, the government laboratories segment accounted for the highest revenue shares of the global sickle cell anemia testing & screening market in 2019, and is expected to continue to do so over the next 10 years. The private-public-partnerships segment is expected to register the fastest rate of revenue growth in the foreseeable future.

Regional Segmentation and Analysis:

North America accounted for the majority revenue share of the global sickle cell anemia testing & screening market in 2019, due to the active number of rolled-out newborn screening programs, which has created a favorable environment for key industry players.

Segmentation of the Global Sickle Cell Anemia Testing & Screening Market:

Segmentation by Technology:

• Hemoglobin Electrophoresis

• Isoelectric focusing
• Others

• High-performance Liquid Chromatography (HPLC)

• Point-of-Care Tests

• Lateral Flow Immunoassay
• Paper-Based Rapid Diagnostics
• Others

• Other Tests

Segmentation by Age Group:

• Newborn Screening (12 months and below)
• Adult Screening (25 to 60 years)
• Other Age Groups (1 to 25 & above 60 years)

Segmentation by Sector Type:

• Government Labs
• Private Labs
• Corporate Labs
• PPP (Public-Private-Partnerships)

Segmentation by Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa